In the largest multicenter study to date on left bundle-branch area pacing (LBBAP), the technique was shown to be feasible as a primary pacing technique for treating bradyarrhythmias and heart failure ...

Multicenter randomized trial (n=200) assigned LBBP versus BiVP for CRT in LBBB with LVEF ≤35%, using time to death or HF hospitalization as primary endpoint. Event rates favored LBBP, reducing death ...

PHILADELPHIA, PA—For patients treated with cardiac resynchronization therapy, use of left bundle branch area pacing (LBBAP) appears to lower arrhythmic risk compared with conventional biventricular ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that Professor Pascal Defaye, Head of Rhythmology ...

Left bundle branch area pacing was found to be an effective and practical strategy for cardiac resynchronization, according to a Late-Breaking Science presentation at EHRA 2026, the annual congress of ...

Please provide your email address to receive an email when new articles are posted on . Left bundle branch pacing was achieved for the first time via leadless pacemaker. Implantation failure rate was ...

(RTTNews) - Abbott (ABT) announced the successful completion of the world's first in-human leadless left bundle branch area pacing procedures using the company's investigational AVEIR Conduction ...

Labeling for a Medtronic pacing lead, already indicated for stimulation of the His bundle, has been expanded to include the left bundle branch (LBB), the company announced today. The US Food and Drug ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded indication for Boston Scientific’s pacemaker leads. The expanded indication ...

Cardiac physiologic pacing, also known as cardiac resynchronization therapy, is indicated in patients with heart failure, reduced left ventricular ejection fraction (LVEF) of 50% or less, and either a ...